Published in Semin Ophthalmol on May 13, 2009
Novel aspects of corneal angiogenic and lymphangiogenic privilege. Prog Retin Eye Res (2010) 1.33
Influence of immune privilege on ocular tumor development. Ocul Immunol Inflamm (2010) 0.97
Influence of CD8+ T regulatory cells on intraocular tumor development. Front Immunol (2012) 0.92
Blocking the path of lymphatic vessels. Nat Med (2009) 0.90
E-Selectin Mediates Immune Cell Trafficking in Corneal Transplantation. Transplantation (2016) 0.79
Comparative evaluation of lymphatic vessels in primary versus recurrent pterygium. Eye (Lond) (2012) 0.78
Conjunctival Lymphangiogenesis Was Associated with the Degree of Aggression in Substantial Recurrent Pterygia. J Ophthalmol (2016) 0.75
Matrix metalloproteinase 14 participates in corneal lymphangiogenesis through the VEGF-C/VEGFR-3 signaling pathway. Exp Ther Med (2016) 0.75
Relations between lymphangiogenesis and the size of pterygium. Int J Ophthalmol (2012) 0.75
Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol (2007) 3.96
Prevalence of dry eye disease among US men: estimates from the Physicians' Health Studies. Arch Ophthalmol (2009) 2.65
Dry eye disease: an immune-mediated ocular surface disorder. Arch Ophthalmol (2012) 2.23
Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression. J Immunol (2009) 2.19
Short-term topical bevacizumab in the treatment of stable corneal neovascularization. Am J Ophthalmol (2012) 2.14
Change in prostaglandin expression levels and synthesizing activities in dry eye disease. Ophthalmology (2012) 2.07
Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation. J Immunol (2009) 2.06
Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision. Proc Natl Acad Sci U S A (2006) 1.81
Corneal sensation and subbasal nerve alterations in patients with herpes simplex keratitis: an in vivo confocal microscopy study. Ophthalmology (2010) 1.80
Topical bevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label, noncomparative study. Arch Ophthalmol (2009) 1.60
Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators. Invest Ophthalmol Vis Sci (2009) 1.42
In Vivo Expansion of Regulatory T Cells by Low-Dose Interleukin-2 Treatment Increases Allograft Survival in Corneal Transplantation. Transplantation (2016) 1.42
Inflammation and the nervous system: the connection in the cornea in patients with infectious keratitis. Invest Ophthalmol Vis Sci (2011) 1.37
Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease. Prog Retin Eye Res (2012) 1.32
A novel mouse model for neurotrophic keratopathy: trigeminal nerve stereotactic electrolysis through the brain. Invest Ophthalmol Vis Sci (2011) 1.27
Validation and repeatability of a short questionnaire for dry eye syndrome. Am J Ophthalmol (2006) 1.24
Contribution of macrophages to angiogenesis induced by vascular endothelial growth factor receptor-3-specific ligands. Am J Pathol (2009) 1.23
Characterization of effector T cells in dry eye disease. Invest Ophthalmol Vis Sci (2009) 1.21
Unilateral herpes zoster ophthalmicus results in bilateral corneal nerve alteration: an in vivo confocal microscopy study. Ophthalmology (2012) 1.20
Efficacy of topical blockade of interleukin-1 in experimental dry eye disease. Am J Ophthalmol (2012) 1.18
Effects of topical and subconjunctival bevacizumab in high-risk corneal transplant survival. Invest Ophthalmol Vis Sci (2009) 1.18
Evidence of corneal lymphangiogenesis in dry eye disease: a potential link to adaptive immunity? Arch Ophthalmol (2010) 1.18
Amelioration of murine dry eye disease by topical antagonist to chemokine receptor 2. Arch Ophthalmol (2009) 1.16
Modulation of integrin alpha4beta1 (VLA-4) in dry eye disease. Arch Ophthalmol (2008) 1.13
Development and validation of a short global dry eye symptom index. Ocul Surf (2007) 1.12
Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes. J Exp Med (2011) 1.10
Characterization of Langerin-expressing dendritic cell subsets in the normal cornea. Invest Ophthalmol Vis Sci (2011) 1.08
A novel pro-lymphangiogenic function for Th17/IL-17. Blood (2011) 1.08
Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin). Ocul Surf (2012) 1.08
Alkali burn to the eye: protection using TNF-α inhibition. Cornea (2014) 1.07
Corneal penetration of topical and subconjunctival bevacizumab. Invest Ophthalmol Vis Sci (2011) 1.07
Regulation of blood vessel versus lymphatic vessel growth in the cornea. Invest Ophthalmol Vis Sci (2008) 1.05
Chemokine receptor CCR5 expression in conjunctival epithelium of patients with dry eye syndrome. Arch Ophthalmol (2006) 1.04
Glycogene expression in conjunctiva of patients with dry eye: downregulation of Notch signaling. Invest Ophthalmol Vis Sci (2008) 1.04
The structure and function of the limbal stem cell and the disease states associated with limbal stem cell deficiency. Int Ophthalmol Clin (2009) 1.03
Donor-derived, tolerogenic dendritic cells suppress immune rejection in the indirect allosensitization-dominant setting of corneal transplantation. J Leukoc Biol (2012) 1.02
Blockade of prolymphangiogenic vascular endothelial growth factor C in dry eye disease. Arch Ophthalmol (2011) 1.01
Ocular graft-versus-host disease: a review. Surv Ophthalmol (2013) 1.00
Interferon-γ-secreting NK cells promote induction of dry eye disease. J Leukoc Biol (2011) 1.00
Dependence of corneal stem/progenitor cells on ocular surface innervation. Invest Ophthalmol Vis Sci (2012) 1.00
International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: proposed diagnostic criteria for chronic GVHD (Part I). Sci Rep (2013) 0.99
High-frequency topical cyclosporine 0.05% in the treatment of severe dry eye refractory to twice-daily regimen. Cornea (2009) 0.98
VEGF-trap aflibercept significantly improves long-term graft survival in high-risk corneal transplantation. Transplantation (2015) 0.96
Differential roles of direct and indirect allorecognition pathways in the rejection of skin and corneal transplants. Transplantation (2009) 0.95
Cellular changes of the corneal epithelium and stroma in herpes simplex keratitis: an in vivo confocal microscopy study. Ophthalmology (2012) 0.95
Effect of topical azithromycin on corneal innate immune responses. Invest Ophthalmol Vis Sci (2011) 0.94
Expression of toll-like receptor 4 contributes to corneal inflammation in experimental dry eye disease. Invest Ophthalmol Vis Sci (2012) 0.94
Vascular endothelial growth factor-C promotes alloimmunity by amplifying antigen-presenting cell maturation and lymphangiogenesis. Invest Ophthalmol Vis Sci (2012) 0.93
The CCR6/CCL20 axis mediates Th17 cell migration to the ocular surface in dry eye disease. Invest Ophthalmol Vis Sci (2013) 0.93
Flt-1 regulates vascular endothelial cell migration via a protein tyrosine kinase-7-dependent pathway. Blood (2011) 0.93
Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable. Br J Ophthalmol (2011) 0.93
Pathways of corneal and ocular surface inflammation: a perspective from the cullen symposium. Ocul Surf (2005) 0.92
Thrombospondin-1 derived from APCs regulates their capacity for allosensitization. J Immunol (2010) 0.92
The international workshop on meibomian gland dysfunction: report of the clinical trials subcommittee. Invest Ophthalmol Vis Sci (2011) 0.92
Effect of desiccating environmental stress versus systemic muscarinic AChR blockade on dry eye immunopathogenesis. Invest Ophthalmol Vis Sci (2013) 0.92
Comparative analysis of human-derived feeder layers with 3T3 fibroblasts for the ex vivo expansion of human limbal and oral epithelium. Stem Cell Rev (2012) 0.91
Blocking the path of lymphatic vessels. Nat Med (2009) 0.90
CCL-21 conditioned regulatory T cells induce allotolerance through enhanced homing to lymphoid tissue. J Immunol (2013) 0.90
Corneal nerve alterations in dry eye-associated ocular surface disease. Int Ophthalmol Clin (2009) 0.90
Gamma-irradiation reduces the allogenicity of donor corneas. Invest Ophthalmol Vis Sci (2012) 0.90
The culture and transplantation of human limbal stem cells. J Cell Physiol (2010) 0.90
Therapeutic efficacy of topical epigallocatechin gallate in murine dry eye. Cornea (2011) 0.90
Chronic ocular surface disease after allogeneic bone marrow transplantation. Ocul Surf (2005) 0.90
Topical ranibizumab as a treatment of corneal neovascularization. Cornea (2013) 0.89
Inflammatory corneal neovascularization: etiopathogenesis. Semin Ophthalmol (2011) 0.89
Regulation of T-cell chemotaxis by programmed death-ligand 1 (PD-L1) in dry eye-associated corneal inflammation. Invest Ophthalmol Vis Sci (2009) 0.88
Nerves and neovessels inhibit each other in the cornea. Invest Ophthalmol Vis Sci (2013) 0.88
A novel function for programmed death ligand-1 regulation of angiogenesis. Am J Pathol (2011) 0.87
Differentiation potential of limbal fibroblasts and bone marrow mesenchymal stem cells to corneal epithelial cells. Stem Cells (2014) 0.87
Corneal endothelial cells are protected from apoptosis by gene therapy. Hum Gene Ther (2011) 0.87
Relapsing polychondritis: systemic and ocular manifestations, differential diagnosis, management, and prognosis. Semin Ophthalmol (2011) 0.87
Role of CCR7 in facilitating direct allosensitization and regulatory T-cell function in high-risk corneal transplantation. Invest Ophthalmol Vis Sci (2009) 0.86
Depletion of passenger leukocytes from corneal grafts: an effective means of promoting transplant survival? Invest Ophthalmol Vis Sci (2009) 0.84
Corneal innervation as a window to peripheral neuropathies. Exp Eye Res (2013) 0.84
Radiotherapy-induced ocular surface disease. Cornea (2005) 0.84
Herpes simplex keratitis and dendritic cells at the crossroads: lessons from the past and a view into the future. Int Ophthalmol Clin (2009) 0.83
b-FGF induces corneal blood and lymphatic vessel growth in a spatially distinct pattern. Cornea (2012) 0.83
A novel pro-angiogenic function for interferon-γ-secreting natural killer cells. Invest Ophthalmol Vis Sci (2014) 0.82
PDE4 inhibition suppresses IL-17-associated immunity in dry eye disease. Invest Ophthalmol Vis Sci (2012) 0.82
Proangiogenic Function of T Cells in Corneal Transplantation. Transplantation (2016) 0.82
Unusual large uniocular elastoid and collagenous pinguecula. Graefes Arch Clin Exp Ophthalmol (2014) 0.81
Onset of ocular graft-versus-host disease symptoms after allogeneic hematopoietic stem cell transplantation. Cornea (2015) 0.81
Trigeminal stereotactic electrolysis induces dry eye in mice. Acta Ophthalmol (2012) 0.81
Bilateral corneal ulceration in ocular graft-versus-host disease. Clin Ophthalmol (2013) 0.81
Extraorbital lacrimal gland excision: a reproducible model of severe aqueous tear-deficient dry eye disease. Cornea (2014) 0.81
Effects of topical Janus kinase inhibition on ocular surface inflammation and immunity. Cornea (2014) 0.80
Delayed type hypersensitivity in the pathogenesis of recurrent herpes stromal keratitis. Semin Ophthalmol (2011) 0.80
Kinetics of Angiogenic Responses in Corneal Transplantation. Cornea (2017) 0.79
E-Selectin Mediates Immune Cell Trafficking in Corneal Transplantation. Transplantation (2016) 0.79
The Ocular Redness Index: a novel automated method for measuring ocular injection. Invest Ophthalmol Vis Sci (2013) 0.78
Outcomes of phacoemulsification in patients with chronic ocular graft-versus-host disease. Graefes Arch Clin Exp Ophthalmol (2015) 0.78
Safety and efficacy of the multitargeted receptor kinase inhibitor pazopanib in the treatment of corneal neovascularization. Invest Ophthalmol Vis Sci (2013) 0.78
Soluble vascular endothelial growth factor receptor-3 suppresses allosensitization and promotes corneal allograft survival. Graefes Arch Clin Exp Ophthalmol (2014) 0.78
Keratoconjunctivitis sicca manifestations in ocular graft versus host disease: pathogenesis, presentation, prevention, and treatment. Semin Ophthalmol (2011) 0.77
Effect of Penetrating Keratoplasty and Keratoprosthesis Implantation on the Posterior Segment of the Eye. Invest Ophthalmol Vis Sci (2016) 0.77
In Vivo Confocal Microscopy in Dry Eye Disease Associated With Chronic Graft-Versus-Host Disease. Invest Ophthalmol Vis Sci (2016) 0.77
Overestimation of Corneal Endothelial Cell Density in Smaller Frame Sizes in In Vivo Confocal Microscopy. Cornea (2016) 0.76
Patients With Dry Eye Disease and Low Subbasal Nerve Density Are at High Risk for Accelerated Corneal Endothelial Cell Loss. Cornea (2017) 0.75
Graft Site Microenvironment Determines Dendritic Cell Trafficking Through the CCR7-CCL19/21 Axis. Invest Ophthalmol Vis Sci (2016) 0.75
Reply: To PMID 22967868. Am J Ophthalmol (2013) 0.75